Nike Inc. (NYSE: NKE) shares experienced notable gains on December 31, 2025, following the disclosure that CEO Elliott Hill ...
Vanda Pharmaceuticals stock surged nearly 19% in premarket trading after receiving FDA approval for NEREUS, the first new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback